Androxal restores normal sperm counts while increasing Testosterone levels in hypogonadal men.

"Dr. Jed Kaminetsky (Department of Urology, New York University Medical Center), the lead investigator noted, “Androxal may fill the need for a drug that is able to restore testicular function and at the same time provide the benefits that normalization of testosterone provides to hypogonadal men. If Androxal can be safely developed, it will represent an important new treatment option for men with secondary hypogonadism with a continued fertility interest.”

No comments:

Post a Comment